February 2021 - Odyssey

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

by Communication Team | Feb 19, 2021 | Publication

Authors: Cecilia L. Moore, Anna Turkova , Hilda Mujuru , Adeodata Kekitiinwa, Abbas Lugemwa, Cissy M. Kityo, Linda N. Barlow-Mosha, et al et al. The ODYSSEY Trial TeamPublished in: BMC Infectious Diseases. Download

New European-African Project that will develop UNIVERSAL treatments for children living with HIV

by Communication Team | Feb 17, 2021 | ODYSSEY

UNIVERSAL, the newly funded European-African clinical research partnership will develop, evaluate and register two new antiretroviral formulations for infants and children newly diagnosed with HIV initiating antiretroviral therapy, and for children failing...

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

New European-African Project that will develop UNIVERSAL treatments for children living with HIV

Recent Posts

Recent Comments

Archives

Categories

Meta